Commentary Open Access
Volume 2 | Issue 1 | DOI: https://doi.org/10.46439/immunol.2.021
Inhibiting hypoxia-inducible factor in T cells strengthens effector-memory function in CD8+ T cells
Fan Pan1,*, Farooq Riaz1, Ping Wei2
- 1Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS), Shenzhen, P. R. China
- 2Department of Otolaryngology, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), China International Science and Technology Cooperation base of Child Development and Critical Disorders, Children’s Hospital of Chongqing Medical University, Chongqing, P. R. China
Corresponding Author
Fan Pan, fan.pan@siat.ac.cn
Received Date: September 10, 2023
Accepted Date: October 19, 2023
Riaz F, Wei P, Pan F. Inhibiting hypoxia-inducible factor in T cells strengthens effector-memory function in CD8+ T cells. J Cell Mol Immunol. 2023;2(1):31-34.
Copyright: © 2023 Riaz F, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Cxcl17 and its association with T cells
We recently published an article describing the importance of CXCL17 in T cell responses [1]. In summary, we observed the following:
1) Cxcl17 is necessary to maintain normal ratios of T cell subpopulations in lymph nodes (LN).
2) Cxcl17-/- mice develop more intense inflammatory responses than wild type mice.
CD4+Foxp3+Helios+regulatory T cells: Role in immunostasis and clinical applications
Since Gershon and Kondo’s initial description of suppressor T cells as antigen-specific T cells that regulate immune responses [1], several advances have taken place on the biology and potential applications of regulatory T cells (Tregs) in clinical settings. After that, Sakaguchi et al. identified Treg cells capable of protecting lymphopenic mice against autoimmune disease produced by neonatal thymectomy [2], and Morrissey et al.
Inhibiting hypoxia-inducible factor in T cells strengthens effector-memory function in CD8+ T cells
In a recent attempt to elucidate the role of HIF1α in modulating the fate of T cells, we have demonstrated that the targeted deletion of HIF1α, specifically in T cells, enhances the inflammatory capabilities and memory phenotype of CD8+ T cells. These findings validate that the T cell-specific ablation of HIF1α or pharmacological inhibition of HIF1α reduces the development of B16F10 melanomas, suggesting an improved anti-tumor immune response characterized by improved secretion of effector molecules, such as IFN-γ, granzyme B, and TNFα, in the CD8+ T cells. Thus, it appears that HIF1α might negatively influence specific effector functions of CD8+ T cells, which are crucial for destroying and targeting tumor cells.
The interplay of regulatory T cells, endoplasmic reticulum stress, and unfolded protein response activation in post-transplant alloimmune hepatitis and autoimmune hepatitis
The incidence and prevalence of autoimmune hepatitis (AIH) globally is 1.28 per 100,000 population-years (95% CI, 1.01-1.63) and 15.65 per 100,000 population (95% CI, 13.42-18.24), respectively [1]. The incidence and prevalence in children is 0.4 and 3.0 cases per 100,000 children [2], and in adults 17 per 100,000 [3,4].
The many faceted role of glycogen synthase kinase-3 (GSK-3) in T cells and cancer immunotherapy
Originally identified for its involvement in phosphorylating glycogen synthase and regulating glucose metabolism in response to insulin, glycogen synthase kinase-3 (GSK-3) has since been recognized as a versatile serine/threonine kinase with diverse functions [1,2]. Extensive research has demonstrated that GSK-3 phosphorylates over 100 protein substrates where it intersects numerous signaling pathways. While it was initially implicated in the regulation of glucose metabolism, subsequent investigations revealed an impact of GSK-3 in cellular processes beyond glycogen synthase phosphorylation and glycogen metabolism [3].